• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Anti-cancer antibody targeting epidermal growth factor receptor with constitutively active mutations

Research Project

  • PDF
Project/Area Number 23590098
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Biological pharmacy
Research InstitutionSunstar Inc. Health Science Institute (2013)
Setsunan University (2011-2012)

Principal Investigator

ITO Fumiaki  サンスター株式会社ヘルスサイエンス研究所, その他部局等, その他 (80111764)

Co-Investigator(Kenkyū-buntansha) NISHIO Kazuto  近畿大学, 医学部, 教授 (10208134)
Project Period (FY) 2011 – 2013
Keywords上皮増殖因子受容体 / チロシンキナーゼ阻害剤 / 抗体医薬 / 抗がん剤
Research Abstract

Lung cancer is the leading cause of death in Japan. Aberrant signaling by epidermal growth factor (EGFR) is found in many cell lung cancer patients, and it leads to uncontrolled cell growth resulting in lung cancer.
Recently, anti-cancer agents (gefitinib and erlotinib) targeting EGFR tyrosine kinases were introduced. Lung cancer patients initially respond well to these anti-cancer agents, but they develop acquired resistance to the agents over time. Therefore, scientists continue to search for new active anticancer agents with better activity.
In this study, we found that antibody against EGFR is incorporated into PC-9 lung cancer cells which display a mutation within the EGFR gene, but not into PC-14 cells which display normal type of EGFR. Then, we conjugated anti-cancer agents (paclitaxel and daunorubicin) to the anti-EGFR antibody. The conjugated antibody showed similar cytotoxic effcts on PC-9 and PC-14 cells and it shows less activity than unconjugated anti-cancer agents.

  • Research Products

    (12 results)

All 2014 2013 2012 2011

All Journal Article (4 results) Presentation (7 results) Book (1 results)

  • [Journal Article] Ent-Kaurane Diterpenoids from Croton Tonkinensis Induce Apoptosis in Colorectal Cancer Cells through the Phosphorylation of JNK Mediated by Reactive Oxygen Species and Dual-Specificity JNK Kinase MKK42014

    • Author(s)
      Phuong Thien Thuong, Nguyen Minh Khoi, Saho Ohta, Shinichiro Shiota, Hironori Kanta, Kenji Takeuchi and Fumiaki Ito
    • Journal Title

      Anti-Cancer Agents in Medicinal Chemistry

      Volume: 14 Pages: 711-721

  • [Journal Article] EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutation2013

    • Author(s)
      Yamada T, Azuma K, Muta E, Kim J, Sugawara S, Zhang GL, Matsueda S, Kasama-Kawaguchi Y, Yamashita Y, Yamashita T, Nishio K, Itoh K, Hoshino T, Sasada T
    • Journal Title

      PLoS ONE

      Volume: 8 Pages: e78389

  • [Journal Article] JNK-mediated FOXO expression plays a critical role in EGFR tyrosine kinase inhibitor-induced BIM expression and apoptosis2012

    • Author(s)
      K.Takeuchi, A.H.Viet, K.Kawasaki, K.Nishio and F.Ito
    • Journal Title

      J Cancer Therapy

      Volume: 3 Pages: 424-434

  • [Journal Article] Receptor Tyrosine kinases and Targeted Cancer Therapeutics2011

    • Author(s)
      K.Takeuchi and F.Ito
    • Journal Title

      Biol.Pharm.Bull

      Volume: 34 Pages: 1774-1780

  • [Presentation] EGFRチロシンキナーゼ阻害剤耐性機構におけるMKP-1の役割2014

    • Author(s)
      竹内健治
    • Organizer
      日本薬学会第134年会
    • Place of Presentation
      熊本
    • Year and Date
      2014-03-28
  • [Presentation] 上皮増殖因子受容体チロシンキナーゼ阻害剤におけるFOXO1の役割2013

    • Author(s)
      渡瀬友貴
    • Organizer
      日本薬学会133年会
    • Place of Presentation
      横浜
    • Year and Date
      2013-03-29
  • [Presentation] GFR活性型変異を有する非小細胞肺がん細胞におけるEGFRの細胞内輸送経路2012

    • Author(s)
      塩田真一朗E
    • Organizer
      第62回日本薬学会近畿支部総会・大会
    • Place of Presentation
      武庫川大学
    • Year and Date
      2012-10-20
  • [Presentation] Antitumor activity and target molecule of ent-kaurane diterpenoids in colorectal cancer cells2012

    • Author(s)
      伊藤文昭
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌
    • Year and Date
      2012-09-21
  • [Presentation] ゲフィチニブ感受性非小細胞肺がん細胞における上皮増殖因子受容体の細胞内経路2012

    • Author(s)
      伊藤文昭
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      札幌
    • Year and Date
      2012-03-30
  • [Presentation] 乃EGFRチロシンキナーゼ阻害剤耐性機構におけるBcl-2ファミリー分子発現誘導の役割2012

    • Author(s)
      新崎さや
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      札幌
    • Year and Date
      2012-03-29
  • [Presentation] ヒト非小細胞肺がんにおいて発現している変異型EGF受容体の細胞内輸送経路の解析2011

    • Author(s)
      塩田真一朗
    • Organizer
      第61回日本薬学会近畿支部総会・大会
    • Place of Presentation
      神戸学院大学
    • Year and Date
      2011-10-22
  • [Book] スタンダード薬学シリーズ4生物系薬学IV.演習編2011

    • Author(s)
      青木隆
    • Total Pages
      283
    • Publisher
      東京化学同人

URL: 

Published: 2015-07-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi